AccessPak for HIV PEP Basic and Histrelin Implant (Prostate Cancer)
Determining the interaction of AccessPak for HIV PEP Basic and Histrelin Implant (Prostate Cancer) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / tenofovir
Brand name: AccessPak for HIV PEP Basic, Descovy, Truvada
Synonyms: n.a.
Generic Name: histrelin
Brand name: Supprelin LA, Vantas, Supprelin
Synonyms: Histrelin (implant), Histrelin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Basic-Histrelin Subcutaneous
- AccessPak for HIV PEP Basic-Histuss PD
- AccessPak for HIV PEP Basic-Hivid
- AccessPak for HIV PEP Basic-Hizentra
- AccessPak for HIV PEP Basic-HMS
- AccessPak for HIV PEP Basic-Hold
- Histrelin Implant (Prostate Cancer)-AccessPak for HIV PEP Expanded with Kaletra
- Histrelin Implant (Prostate Cancer)-AccessPak for HIV PEP Expanded with Viracept
- Histrelin Implant (Prostate Cancer)-Accolate
- Histrelin Implant (Prostate Cancer)-Accretropin
- Histrelin Implant (Prostate Cancer)-Accucaine
- Histrelin Implant (Prostate Cancer)-AccuHist Drops